novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Mobile-health. A big challenge for contemporary medicine – Daniel Ferreira

27 Setembro 2017

Resumo da apresentação

Apresentação

Daniel Ferreira
PT

Chronic stable angina beyond revascularization - Lopez Sendon

20 Setembro 2017
0

European Cardiovascular Disease Statistics 2017

28 Setembro 2017
0

-->